EVAX
Price
$0.88
Change
-$0.08 (-8.33%)
Updated
Dec 18, 04:59 PM (EDT)
VNDA
Price
$4.56
Change
-$0.17 (-3.59%)
Updated
Dec 18, 04:59 PM (EDT)
49 days until earnings call
Ad is loading...

EVAX vs VNDA

Header iconEVAX vs VNDA Comparison
Open Charts EVAX vs VNDABanner chart's image
Evaxion Biotech A/S American Depositary Share
Price$0.88
Change-$0.08 (-8.33%)
Volume$367
CapitalizationN/A
Vanda Pharmaceuticals
Price$4.56
Change-$0.17 (-3.59%)
Volume$10.21K
CapitalizationN/A
EVAX vs VNDA Comparison Chart
Loading...
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVAX vs. VNDA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Hold and VNDA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (EVAX: $0.96 vs. VNDA: $4.73)
Brand notoriety: EVAX and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 297% vs. VNDA: 56%
Market capitalization -- EVAX: $5.61M vs. VNDA: $275.8M
EVAX [@Biotechnology] is valued at $5.61M. VNDA’s [@Biotechnology] market capitalization is $275.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, VNDA is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • EVAX’s TA Score: 4 bullish, 4 bearish.
  • VNDA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, EVAX is a better buy in the short-term than VNDA.

Price Growth

EVAX (@Biotechnology) experienced а -25.87% price change this week, while VNDA (@Biotechnology) price change was +2.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

EVAX is expected to report earnings on May 09, 2024.

VNDA is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($265M) has a higher market cap than EVAX($5.61M). VNDA YTD gains are higher at: 12.085 vs. EVAX (-86.054). EVAX has higher annual earnings (EBITDA): -9.38M vs. VNDA (-30.16M). VNDA has more cash in the bank: 376M vs. EVAX (4.58M). VNDA has less debt than EVAX: VNDA (7.94M) vs EVAX (10.5M). VNDA has higher revenues than EVAX: VNDA (191M) vs EVAX (3.3M).
EVAXVNDAEVAX / VNDA
Capitalization5.61M265M2%
EBITDA-9.38M-30.16M31%
Gain YTD-86.05412.085-712%
P/E RatioN/A126.00-
Revenue3.3M191M2%
Total Cash4.58M376M1%
Total Debt10.5M7.94M132%
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVAXVNDA
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 23 days ago
81%
Bullish Trend 2 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WLIVX15.210.03
+0.20%
WCM Focused International Equity Inv
BNIEX10.20-0.02
-0.22%
UBS International Sustainable Equity A
VGRIX79.60-0.57
-0.71%
JPMorgan US Value A
QTENX10.52-0.10
-0.94%
AQR Emerging Multi-Style II N
QASCX26.62-0.33
-1.22%
Federated Hermes MDT Small Cap Core A

EVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVAX has been loosely correlated with SPRC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EVAX jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
-8.92%
SPRC - EVAX
37%
Loosely correlated
+0.31%
KURA - EVAX
35%
Loosely correlated
-2.36%
SPRB - EVAX
27%
Poorly correlated
+4.04%
REPL - EVAX
26%
Poorly correlated
-6.09%
VNDA - EVAX
26%
Poorly correlated
+2.16%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with AMLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+2.16%
AMLX - VNDA
42%
Loosely correlated
+2.39%
GOSS - VNDA
37%
Loosely correlated
+1.71%
IKNA - VNDA
37%
Loosely correlated
+0.62%
VCYT - VNDA
36%
Loosely correlated
-2.52%
ATRA - VNDA
34%
Loosely correlated
-1.52%
More